Author:
Liu Mingdi,Liu Jichao,Wang Qiuhong,Song Ping,Li Haichao,Sun Zan,Shi Chenglong,Dong Weibing
Funder
National Natural Science Foundation of China
Natural Science Foundation of Qinghai Province
Reference42 articles.
1. R. Hilfiker, Polymorphism: in the pharmaceutical industry, 1st ed., Boschstraße, Weinheim, 2006. https://doi.org/10.1002/3527607889.
2. Q6A International Conference on Harmonization, Guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances, Federal Register 65 (2000) 83041-83063.
3. H.G. Brittain, Polymorphism in Pharmaceutical Solids, 2nd ed., Pinehurst, North Carolina, 2009. https://doi.org/10.3109/9781420073225.
4. Pharmaceutical solid polymorphism in drug development and regulation;Raw;Adv. Drug Delivery Rev.,2004
5. A.F. Abdel-Magid, M. Chisholm, S. Mehrman, L. Scott, K.M. Wells, F. Zhang-Plasket, Process for the preparation of compounds useful as inhibitors of SGLT, WO patent (2009) 2009035969A1.